Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Payables (2009 - 2025)

Grifols' (GIFLF) quarterly Payables came in at $1.3 billion in Q4 2025, up 8.45% on a YoY basis from $1.2 billion in Q4 2024, and up 8.45% quarter-over-quarter from $1.2 billion in Q4 2024.

Analysis

Grifols (GIFLF) Payables (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Payables for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 8.45% year-over-year to $1.3 billion; the trailing twelve-month figure through Dec 2025 stood at $1.3 billion (up 8.45% YoY), and the FY2025 full-year result was $1.3 billion, up 5.26% from the prior year.
  • Payables climbed to $1.3 billion in Q4 2025 per GIFLF's latest filing, from $1.2 billion in the prior quarter.
  • Across five years, Payables topped out at $1.3 billion in Q4 2025 and bottomed at $898.4 million in Q4 2021.
  • Historically, Payables has averaged $1.1 billion across 5 years, with a median of $1.0 billion in 2023.
  • The sharpest annual moves came in 2021 and 2024: Payables increased 0.98% in 2021, then advanced 14.91% in 2024.
  • Over 5 years, Payables stood at $898.4 million in 2021, then rose by 4.32% to $937.2 million in 2022, then advanced by 11.44% to $1.0 billion in 2023, then rose by 14.91% to $1.2 billion in 2024, then climbed by 8.45% to $1.3 billion in 2025.
  • According to Business Quant data, Payables over the past three periods registered $1.3 billion, $1.2 billion, and $1.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 1.52 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 108.02 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 25.08 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 1.30 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Bn
Dec 31, 2024 1.20 Bn
Dec 31, 2023 1.04 Bn
Dec 31, 2022 937.18 Mn
Dec 31, 2021 898.41 Mn
Dec 31, 2020 889.67 Mn
Dec 31, 2019 834.02 Mn
Dec 31, 2018 825.93 Mn
Jun 30, 2018 705.10 Mn
Dec 31, 2017 672.93 Mn
Jun 30, 2017 599.76 Mn
Dec 31, 2016 660.71 Mn
Sep 30, 2016 554.06 Mn
Jun 30, 2016 601.04 Mn
Dec 31, 2015 583.52 Mn
Sep 30, 2015 521.18 Mn
Jun 30, 2015 616,137.26
Mar 31, 2015 635.73 Mn
Dec 31, 2014 772.47 Mn
Sep 30, 2014 660.83 Mn